Contract 75D30124D19009
Pfizer Inc · Department Of Health And Human Services · June 25, 2024
Pfizer Inc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on June 25, 2024 for $91.53 million of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 6 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 21, 2025. If all options are exercised, the contract could reach $1.10 billion.
Contract details
- PIID
- 75D30124D19009
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- June 25, 2024
- Latest action
- November 21, 2025
Description
COVID-19 PEDIATRIC VACCINES
Modification timeline
-
November 21, 2025Mod P00008 · Other Administrative Action$91.55M
-
July 23, 2025Mod P00007 · Supplemental Agreement For Work Within Scope$178.47M
-
July 16, 2025Mod P00006 · Supplemental Agreement For Work Within Scope$178.47M
-
September 6, 2024Mod P00004 · Funding Only Action$178.47M
-
August 22, 2024Mod P00003 · Other Administrative Action$178.26M
-
July 31, 2024Mod P00002 · Funding Only Action$178.26M
-
June 25, 2024Mod P00001 · Supplemental Agreement For Work Within Scope$21.4K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30124D19009?
Contract 75D30124D19009 is a federal contract awarded to Pfizer Inc by Department Of Health And Human Services on June 25, 2024 for $91.53 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 6 times since the base award.
Who won contract 75D30124D19009?
Pfizer Inc won contract 75D30124D19009 from Department Of Health And Human Services.
How much is contract 75D30124D19009 worth?
Contract 75D30124D19009 has obligated $91.53 million to date, with a total potential value of $1.10 billion if all options are exercised.